Insider Transactions in Q3 2022 at Oramed Pharmaceuticals Inc. (ORMP)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 08
2022
|
Leonard Sank Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,304
-24.48%
|
$74,432
$8.77 P/Share
|
|
Aug 08
2022
|
Leonard Sank Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+34.48%
|
$80,000
$4.08 P/Share
|
|
Aug 01
2022
|
Nadav Kidron President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,631
-1.16%
|
$101,048
$8.36 P/Share
|
|
Jul 28
2022
|
Yadin Rozov Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+42.11%
|
-
|
|
Jul 28
2022
|
Leonard Sank Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+40.0%
|
-
|
|
Jul 28
2022
|
David Silberman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,000
+26.53%
|
-
|
|
Jul 28
2022
|
Michael Rabinowitz Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+17.7%
|
-
|
|
Jul 28
2022
|
Arie Mayer Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+40.0%
|
-
|
|
Jul 28
2022
|
Miriam Kidron Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
118,000
+17.65%
|
-
|
|
Jul 28
2022
|
Nadav Kidron President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
160,000
+6.88%
|
-
|
|
Jul 28
2022
|
Joshua Hexter COO & CBO |
BUY
Grant, award, or other acquisition
|
Direct |
42,000
+20.16%
|
-
|
|
Jul 28
2022
|
Netanel Derovan Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+38.46%
|
-
|